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OBJECTIVE—To compare the microcirculatory velocity distri-
bution in type 2 diabetic patients and nondiabetic control sub-
jects at baseline and after local heating.
RESEARCH DESIGN AND METHODS—The skin blood ﬂow
response to local heating (44°C for 20 min) was assessed in 28
diabetic patients and 29 control subjects using a new velocity-
resolved quantitative laser Doppler ﬂowmetry technique (qLDF).
The qLDF estimates erythrocyte (RBC) perfusion (velocity 
concentration), in a physiologically relevant unit (grams RBC per
100 g tissue  millimeters per second) in a ﬁxed output volume,
separated into three velocity regions: v 1 mm/s, v 1–10 mm/s,
and v 10 mm/s.
RESULTS—The increased blood ﬂow occurs in vessels with a
velocity 1 mm/s. A signiﬁcantly lower response in qLDF total
perfusion was found in diabetic patients than in control subjects
after heat provocation because of less high-velocity blood ﬂow (v
10 mm/s). The RBC concentration in diabetic patients in-
creased sevenfold for v between 1 and 10 mm/s, and 15-fold for
v 10 mm/s, whereas no signiﬁcant increase was found for v 1
mm/s. The mean velocity increased from 0.94 to 7.3 mm/s in
diabetic patients and from 0.83 to 9.7 mm/s in control subjects.
CONCLUSIONS—The perfusion increase occurs in larger
shunting vessels and not as an increase in capillary ﬂow. Baseline
diabetic patient data indicated a redistribution of ﬂow to higher
velocity regions, associated with longer duration of diabetes. A
lower perfusion was associated with a higher BMI and a lower
toe-to-brachial systolic blood pressure ratio. Diabetes 59:1578–
1584, 2010
L
aser Doppler ﬂowmetry (LDF) has frequently
been used to measure blood ﬂow abnormalities in
diabetic patients (1–5). A reduced vascular re-
sponse to local heating, due to loss of the active
neurogenic vasodilation, has been observed in type 1 and
type 2 diabetic patients using LDF (1,6) and caused by loss
in endothelium nitric oxide (NO) synthesis in type 2
diabetic patients (7). Another microvascular abnormality
has also been suggested—an increased ﬂow through the
arteriovenous shunts resulting in a reduced capillary ﬂow
(8–12). This is most evident during provocations such as
postocclusive reactive hyperemia and in patients with
severe neuropathy, but it can also be observed in diabetic
patients at rest who have no complications (11).
Although differences in blood ﬂow between diabetic
patients and control subjects have been found using LDF
during heating and other provocation protocols, results
during baseline conditions have been more contradictory
(6). Studies have reported a lower blood ﬂow in diabetic
patients compared with control subjects (3), no difference
(1,4), and even tendencies toward a higher blood ﬂow in
diabetic patients (11). The conﬂicting results are partly
explained by the different measurement positions used, for
which differences have been seen especially between
glabrous (e.g., palms and soles) and nonglabrous (hairy)
skin (6). Although authors usually specify the measure-
ment position in detail, unfortunately it is common that
the speciﬁcation of the LDF instrumentation used is omit-
ted, in terms of operating wavelength and probe type/
source-detector separation. The measurement depth is
highly dependent on these two properties, especially the
latter (13), and therefore some of the discrepancies in the
reported results may be explained by the differences in
instrumentation.
Local warming of skin causes a biphasic increase in skin
blood ﬂow as measured by LDF. The initial increase in
blood ﬂow that sometimes temporarily declines is medi-
ated by a C-ﬁber axon reﬂex, whereas the second pro-
longed phase requires NO (14,15). These and other studies
use LDF for elucidating NO synthase mechanisms
(5,7,16,17) for quantiﬁcation of abnormalities in the endo-
thelium-dependent NO vasodilation (18) and other micro-
vascular research issues (19,20).
Studying the microcirculation in a clinical setting using
LDF may be difﬁcult because the method provides only
relative measures on skin blood ﬂow (14). Large local
spatial and temporal variations in blood ﬂow have also
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an unknown measurement volume that varies not only
with instrumentation but also with the optical properties
at the measurement site and with variations in the blood
ﬂow itself (13). This further obstructs the physiologic
interpretation of the results.
We have developed a new LDF signal analysis based on
simulations of light transport in an adaptive mathematical
model of tissue. As the perfusion estimates achieved with
this method are presented in physiologically relevant units
(grams erythrocytes [RBC]/100 g tissue  mm/s) in a given
output volume (3 mm
3), the method is called quantitative
LDF (qLDF). Besides the beneﬁts of a constant output
volume and physiologically relevant units, the method also
provides a means of differentiating the blood ﬂow into
various ﬂow velocity regions (22). This velocity differen-
tiation can potentially be used to associate differences in
the velocity distribution to speciﬁc vessel types because
large vessels normally have a much higher blood ﬂow
velocity than smaller vessels.
The aim of the present study was to compare the
velocity distribution of the microcirculatory blood ﬂow
between patients with diabetes type 2 and normal control
subjects during baseline and local warming. To our knowl-
edge, this has previously not been possible, and the
differences in the velocity distribution can be used to draw
conclusions about the type of vessels that are mainly
involved in the pathologic disturbances of the microcircu-
lation in diabetes type 2.
RESEARCH DESIGN AND METHODS
The patients included in this study are part of a larger study called Cardio-
vascular Risk Factors in Patients with Diabetes—a Prospective Study in
Primary Care (CARDIPP) that was launched in 2005 with the aim of identify-
ing markers for cardiovascular disease to facilitate earlier and individually
adjusted intervention in middle aged patients with type 2 diabetes. The
nondiabetic control subjects were part of a parallel control study called
CAREFUL. Within the CARDIPP and CAREFUL studies, parameters such as
height, weight, and blood pressure were measured. The investigation included
medical history, also covering data on diabetes duration and ongoing medi-
cation. Blood specimens were drawn in the morning after a 10-h overnight
fast. Aortic pulse wave velocity was measured with an applanation tonometry
(Sphygmocor) over the carotid and femoral arteries as an indicator of arterial
stiffness. Intima-media thickness of the carotid arteries was evaluated using a
B-mode ultrasound, as a measure of subclinical atherosclerosis. The toe-
brachial index (TBI) (toe systolic blood pressure–to–brachial systolic blood
pressure ratio) was used as a measure of peripheral arterial disease. (For
more details about these studies, see refs. 23 and 24.) The protocol was
approved by the local ethics committee (D. no. M26-05).
Based on accessibility, a small number of the subjects included in
CARDIPP and CAREFUL were asked to join the extended study in which
microcirculatory parameters in the foot were also measured using a modiﬁed
LDF instrument (Perimed, Ja ¨rfa ¨lla, Sweden). Recordings were made using a
custom-made probe with 1 light-emitting ﬁber placed in the center, 1 light-
collecting ﬁber placed 0.25 mm (center-to-center distance) from the light-
emitting ﬁber, and another 11 light-collecting ﬁbers placed in a circle 1.2  0.1
mm from the light-emitting ﬁber. All ﬁbers were made of silica with a 0.125
mm diameter and NA 0.37, and the light source was a 780 nm laser diode.
Backscattered light collected at the two source-detector distances was
separately detected and sampled at 50 kHz for later analysis. The measure-
ment probe was placed in a thermostatic probe holder (PF 450; Perimed) that
was able to adjust the skin temperature and assured a minimum pressure
contact between the probe tip and the examined skin. All measurements were
performed on the dorsum of one foot 3–6 cm proximal of the toes between the
metatarsals, avoiding visible vessels (1). The recordings lasted for 25 min. In
the beginning of the recording, the probe holder was heated to 32°C, deﬁned
as the baseline, and after approximately 5 min, the temperature was increased
to 44°C, which lasted throughout the rest of the measurement. All measure-
ments were performed in a room kept at a temperature of 23–25°C and the
subjects were placed in the supine position. The subjects were acclimatized in
the room for at least 15 min before the measurement. The measurements were
done at approximately the same time of day for the two groups, at mean 11:58
A.M. (SD 1.51 h) for control subjects and at 11:13 A.M. (1:32 h) for diabetic
patients. The extended protocol was approved by the local ethics committee
(D. no. M26-05 T41-08).
From the recorded signals, Doppler power spectra were calculated,
calibrated, and averaged in 5-s intervals for the two different source-detector
separations (22,25). Conventional LDF perfusion measures (26) were calcu-
lated for both separations from the calculated and averaged Doppler power
spectra. These measures are given in arbitrary units with unknown and
nonconstant sampling volumes. Besides the conventional perfusion measures,
the quantitative LDF method was used to estimate the perfusion in a
physiologically relevant unit (grams RBC per 100 g tissue  millimeters per
second). The value is relevant for an output volume ofa3m m
3 half-sphere,
that is, within a 1.13 mm radius from the emitting ﬁber. The perfusion measure
is divided into three velocity regions: v 1 mm/s, 1  v  10 mm/s, and v 10
mm/s. Furthermore, the total perfusion is also presented (sum of all three
regions). The method, presented in Fredriksson et al. (22), is based on a model
adaption of the Doppler power spectra to the measured spectra at the two
source-detector separations simultaneously.
Blood perfusion was measured in 28 diabetic patients and in 29 control
subjects. Three diabetic patients and 3 control subjects were excluded
because of varicose veins, 1 diabetic patient was excluded because of a skin
surface temperature above 32°C, 1 control patient was excluded because of
chronic obstructive pulmonary disease, and 1 control patient was excluded
because of suspected poor contact between the probe and the skin. In two of
the measurements, one for a diabetic patient and one for a control subject, the
method was not able to ﬁnd a model that matched the measured spectra (
2
0.5) and they were therefore excluded. The remaining diabetic patients and
control subjects are described in Table 1. Among the 23 included diabetic
patients, 7 were treated with diet and exercise only, 13 were also treated with
oral hypoglycemic agents but no insulin, and 3 were treated with insulin.
Eleven diabetic patients were taking metformin, 2 were taking sulfonylureas,
2 were taking thiazolidinediones, and 1 was treated with a dipeptidyl
peptidase IV inhibitor. Three individuals did not take any antihypertensive
TABLE 1
Characteristics of diabetes patients and nondiabetic control
subjects
Control
subjects
Diabetic
patients
n 23 23
Sex (M/F) 8/15 14/9
Age (years) 62  66 0  3
Diabetes duration (years) NA 7  6
Height
Men (cm) 178  7 176  7
Women (cm) 166  7 164  5
Weight
Men (kg) 84  16 91  8
Women (kg) 67  10 78  9*
BMI (kg/m
2) 25  32 9  3‡
Glucose (mmol/l) 6.0  0.8§ 8.1  2.1‡§
Triglyceride (mmol/l) 1.3  0.8 1.9  1.4*¶
Cholesterol (mmol/l) 5.8  1.0 4.2  0.6‡¶
LDL cholesterol (mmol/l) 3.5  0.8§ 2.4  0.6‡#
HDL cholesterol (mmol/l) 1.7  0.6 1.1  0.3‡¶
A1C (%) NA 6.0  0.9§
Systolic blood pressure (mmHg) 120  12 122  10
Diastolic blood pressure (mmHg) 74  87 2  7
Pulse wave velocity (m/s) 8.9  1.7 11.2  2.0‡¶
Left ventricular mass
Men (g) 106  11 127  34
Women (g) 106  29 93  36§
Carotid intima-media
thickness (mm) 0.67  0.12 0.75  0.13*
TBI 0.89  0.16¶ 0.93  0.12
Data are means  SD. Statistical comparisons of diabetic patients vs.
nondiabetic control subjects: *P  0.05, ‡P  0.001. §One value
missing; two values missing; ¶three values missing; #ﬁve values
missing.
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inhibitors or angiotensin receptor blockers (14 subjects), followed by 8
subjects taking -blockers, 5 taking diuretics, and 4 taking calcium channel
blockers. Twenty subjects were treated with statins. Four subjects were
current smokers, and 12 were former smokers. Microalbuminuria, deﬁned as
an albumin-to-creatinine ratio 30 g/mg, was present in 1 subject. History of
cardiovascular disease was prevalent in 3 subjects. The baseline measurement
was excluded for 3 diabetic patients because of a too short acclimatization
period (15 min).
Statistical comparisons between diabetic patients and control subjects
were performed using the nonparametric Mann-Whitney U test. Bivariate
correlations were evaluated using Pearson product-moment analysis. Outlier
data were excluded in the correlation analysis, using an upper limit of the
mean  3 SD of diabetic patient data. P  0.05 was considered signiﬁcant.
RESULTS
Examples of the qLDF perfusion measures during the heat
provocation are shown in Fig. 1. In Fig. 1A, typical
behavior of the perfusion in the three different velocity
regions is shown. Only a small increase was found in the
low-velocity region, whereas a larger increase occurred in
the mid- and high-velocity regions. In Fig. 1B, two typical
heat responses of the total perfusion (all velocities) are
shown. In the ﬁrst case (Fig. 1B, circles), the perfusion
decreases after the initial heat-induced increase, and
shortly thereafter the perfusion increases again. In the
second case (squares), this biphasic response is not visible
and the perfusion quickly settles on a more or less
constant level after the temperature rise. Both types of
responses occurred in both diabetic patients and controls
and were approximately equally common. In Fig. 2, a
comparison of the response of the qLDF perfusion esti-
mate and the conventional LDF (cLDF) perfusion esti-
mates at the two source-detector separations is shown.
The cLDF perfusion estimates have been normalized so
that they equal the qLDF perfusion estimate during base-
line (the ﬁrst 5 min). It can be seen that the heat response
is much higher for the qLDF perfusion estimate than for
the cLDF. On average for all 20 included diabetic patients
(the 3 diabetic patients with too short acclimatization
excluded), a 1,065% increase was observed in the qLDF
total perfusion, whereas the increase was 672 and 502%
for the cLDF perfusion estimates at 0.25- and 1.2 mm
source-detector separation, respectively. Corresponding
increases for the 23 control subjects were 1,755, 1,046, and
734%, respectively.
A summary of the cLDF and qLDF perfusion measures is
given in Table 2. Values are given for baseline, that is, the
median during the ﬁrst 5 min when the probe holder was
heated to 32°C, and for the plateau of the heat provocation
response, that is, the median of the last 5 min. No
signiﬁcant differences were found at baseline. For the
plateau, signiﬁcant differences between diabetic patients
and control subjects were found for cLDF using both
source-detector separations (0.25 and 1.2 mm) and for
qLDF total perfusion and for velocities 10 mm/s. A
similar analysis of the perfusion during the initial peak in
the heat response, that is, the median over 2 min starting
2 min after the heat onset, showed that both cLDF
measures and qLDF total perfusion were signiﬁcantly
lower for diabetic patients than for control subjects (data
not presented).
Bivariate correlation analysis for diabetic patient data
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FIG. 1. Typical response of the perfusion in the three different velocity regions (A) and two typical responses of the total perfusion (B).
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FIG. 2. Differences in response to heat stimuli between the qLDF
perfusion estimate and the cLDF perfusion estimates at the two ﬁber
separations. The cLDF estimates are normalized to equal the average
baseline level of the qLDF perfusion estimate.
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conventional LDF perfusion estimates, the quantitative
perfusion in the different velocity regions and the total
perfusion, the concentration of moving blood cells (Table
3) and their average velocity (Table 4), versus duration of
diabetes, A1C and TBI. Signiﬁcant correlations were found
at baseline for duration versus the quantitative perfusion
in the low-velocity region (R 	
 0.46, P  0.05) and in the
mid-velocity region (R 	 0.48, P  0.05), the average
velocity (R 	 0.63, P  0.01), and the average concentra-
tion (R 	
 0.55, P  0.05). The relations between duration
and qLDF data at baseline are presented in Fig. 3. No
signiﬁcant correlations were found for A1C versus any of
the perfusion estimates. Signiﬁcant correlations were
found after heat for TBI versus the conventional perfusion
at 1.2 mm separation (R 	 0.42, P  0.05), the quantitative
total perfusion (R 	 0.42, P  0.05), and the average
velocity (R 	 0.46, P  0.05). The relations between TBI
and qLDF data after heat are presented in Fig. 4.
Bivariate correlation analysis for control data were
performed at baseline and after heat for the two conven-
tional LDF perfusion estimates, the quantitative perfusion
in the different velocity regions and the total perfusion, the
concentration of moving blood cells and their average
velocity, versus TBI. No signiﬁcant correlations were
found.
Bivariate correlations between the cLDF perfusions at
both ﬁber distances and the total qLDF perfusion and BMI,
LDL, glucose level, and pulse wave velocity, respectively,
were performed for diabetic patients and control subjects
separately after heat provocation. No signiﬁcant correla-
tion was found in the control group between any LDF
perfusion measure and any clinical variable. For diabetic
patients, LDL was related to cLDF perfusion at 0.25 mm
separation (R 	
 0.49, P  0.05) and BMI was related or
borderline related to three perfusion measures (cLDF
perfusion at 0.25 mm ﬁber separation, R 	
 0.49, P  0.05;
cLDF perfusion at 1.2 mm ﬁber separation, R 	
 0.40, P 
0.06; qLDF total perfusion R 	
 0.41, P  0.06).
DISCUSSION
In about half of the measurements, both for the diabetic
patients and control subjects, a distinct biphasic heat
response could be observed. The ﬁrst part of this biphasic
response is foremost related to the fast axon reﬂex,
whereas the second part is related to the NO-induced
response (14,15). In the measurements where this biphasic
response is not visible, the two phases are overlapping.
The biphasic response becomes more evident when the
heat increase is slower (15). An attenuated response has
previously been reported for both the axon reﬂex and the
NO-induced response in diabetic type 2 patients (7,27) and
a signiﬁcant difference between diabetic patients and
control subjects in the increase from baseline to both the
initial peak and the late plateau was also found in the
current study. The level of the increase was similar to that
reported by Colberg et al. (1), who used a similar protocol.
Figure 2 shows an example of the perfusion response to
heat for both the cLDF perfusion estimates at the two
different source-detector separations and for the qLDF
TABLE 3
cLDF and qLDF concentration of moving blood cells at baseline and at the plateau
LDF Time
Fiber
separation/velocity Control subjects Diabetic patients
n 23 23
c B 0.25 mm separation 0.61  0.18 0.57  0.16¶
c B 1.2 mm separation 0.86  0.14 0.83  0.084¶
qB v 1 mm/s 0.085  0.064 0.069  0.027¶
qB 1  v  10 mm/s 0.0064  0.0034 0.0075  0.0034¶
qB v 10 mm/s 0.00,076  0.00032 0.00,091  0.00033¶
q B All v 0.092  0.065 0.077  0.027¶
c Pl 0.25 mm separation 0.78  0.12 0.74  0.14
c Pl 1.2 mm separation 0.96  0.05 0.96  0.046
qP l v 1 mm/s 0.039  0.043 0.061  0.090
qP l 1  v  10 mm/s 0.056  0.022 0.048  0.017
qP l v 10 mm/s 0.018  0.0069 0.013  0.0052*
q Pl All v 0.11  0.051 0.12  0.083
Data are means  SD. cLDF was measured using 0.25- and 1.2 mm ﬁber separations. qLDF was measured in different velocity regions. B,
baseline, median over ﬁrst 5 min; c, conventional, arbitrary units; q, g RBC/100 g tissue; Pl, plateau, median over last 5 min. ¶The baseline
measurements were excluded for three diabetic patients because of too short acclimatization. Statistical comparisons of diabetic patients vs.
normal control subjects: *P  0.05.
TABLE 2
cLDF and qLDF perfusion estimates at baseline and at the
plateau
LDF Time
Fiber
separation/velocity
Control
subjects
Diabetic
patients
n 23 23
c B 0.25 mm separation 46  12 46  15¶
c B 1.2 mm separation 242  84 260  55¶
qB v 1 mm/s 0.019  0.012 0.016  0.005¶
qB 1  v 10 mm/s 0.016  0.009 0.019  0.009¶
qB v 10 mm/s 0.026  0.012 0.032  0.015¶
q B All v 0.061  0.025 0.067  0.019¶
c Pl 0.25 mm separation 485  215 335  113†
c Pl 1.2 mm separation 1,842  562 1,491  396*
qP l v 1 mm/s 0.017  0.019 0.021  0.018
qP l 1  v 10 mm/s 0.20  0.08 0.16  0.06
qP l v 10 mm/s 0.77  0.42 0.53  0.26*
q Pl All v 0.98  0.44 0.71  0.28*
Data are means  SD. cLDF was measured using 0.25- and 1.2 mm
ﬁber separations. qLDF was measured in different velocity regions.
B, baseline, median over ﬁrst 5 min; c, conventional, arbitrary units;
q, g RBC/100 g tissue  mm/s; Pl, plateau, median over last 5 min.
¶Baseline measurements were excluded for three diabetic patients
because of too short acclimatization. Statistical comparisons of
diabetic patients vs. control subjects: *P  0.05; †P  0.01.
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from baseline to the late plateau was higher for the
qLDF than for the cLDF estimates. The response for the
1.2 mm source-detector separation was weaker than for
the 0.25 mm separation for the cLDF estimates. Actu-
ally, the increase for qLDF was higher than the increase
in the cLDF for all measurements but one, and the
increase for the long ﬁber separation was generally lower
than the increase for the short one. This difference be-
tween the qLDF and cLDF perfusion estimates is due to
the well-known nonlinearity to the blood tissue fraction in
cLDF perfusion, which is not present in qLDF perfusion
(22). The nonlinearity is not severe, nor does it have a
great impact on the results in this study. However, when
measuring on sites with higher blood tissue fraction than
the dorsum of the foot, which has a relatively low blood
tissue fraction, this may be of major importance. A method
has previously been presented to compensate for the
nonlinearity in the cLDF perfusion estimates (28). How-
ever, that method was designed and evaluated using
plastic phantoms, and its usefulness for in vivo measure-
ments has been questioned by others (29,30).
Table 2 shows that the high velocities are affected the
most by the heat provocation and that they also differ the
most between the diabetic patients and the control sub-
jects. In contrast, no signiﬁcant increase is found in the
perfusion for the lowest velocity region, and no signiﬁcant
difference between the diabetic patients and the control
subjects is found in the two lowest velocity regions.
Knowing that the thermoregulation involves mostly the
larger vessels in the microcirculation where the velocity is
generally higher, it is expected that the high velocities are
affected the most by the heat provocation. The unchanged
low-velocity ﬂow and the highly increased high-velocity
ﬂow indicate that the increased ﬂow due to the heat
provocation is shunted from the artery to the vein side.
The lower increase of the high-velocity blood ﬂow for
TABLE 4
cLDF and qLDF velocity estimates at baseline and at the plateau
LDF Time
Fiber
separation/velocity
Control
subjects
Diabetic
patients
n 23 23
c B 0.25 mm separation 78  20 84  26¶
c B 1.2 mm separation 288  110 313  66¶
q B All v 0.83  0.40 0.94  0.37¶
c Pl 0.25 mm separation 627  317 461  165*
c Pl 1.2 mm separation 1,925  629 1,558  438*
q Pl All v 9.7  4.7 7.3  3.9*
Data are means  SD. cLDF was measured using 0.25- and 1.2 mm
ﬁber separations. qLDF was measured in different velocity regions.
B, baseline, median over ﬁrst 5 min; c, conventional, arbitrary units;
q, mm/s; Pl, plateau, median over last 5 min. ¶The baseline measure-
ments were excluded for three diabetic patients because of too short
acclimatization. Statistical comparisons of diabetic patients vs. nor-
mal control subjects: *P  0.05.
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FIG. 3. Relation between diabetes duration and quantitative LDF perfusion in low-velocity (A) and mid-velocity (B) region, average velocity (C),
and the concentration of moving erythrocytes (D) at baseline. Diabetes treatments were insulin (F), oral hypoglycemic agents (‚), and diet and
exercise (), respectively.
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strongly suggests that the maximal arteriovenous shunting
capacity is reduced in diabetic patients. Furthermore, a
decreasing perfusion response to heat was associated with
increasing BMI and decreasing TBI and, similarly, a de-
creasing average velocity with decreasing TBI. These
relationships were observed only in diabetic patients and
not in control subjects. The clinical importance of these
ﬁndings remains to be answered in the future.
Relatively large SDs were found for all perfusion esti-
mates presented in Table 2, both at baseline and during the
heat provocation. This may not only reﬂect intraindividual
differences but may also be a result of large spatial
inhomogeneities in the microcirculation (21). Although
Colberg et al. (1) argue that performing the measurements
in a thermoneutral environment should reduce these inho-
mogeneities, which should be further reduced by the 32°C
baseline level of the probe holder, the study would have
beneﬁted from measurements at multiple sites. For base-
line measurements that must not exceed a few minutes,
multiple measurement sites are recommended for future
studies. Another limitation of this study is that we were
not able to control for differences in antihypertensive
medication between the two groups.
As stated in the Introduction, results concerning the
microvascular blood ﬂow in diabetic patients in baseline
have been contradictory (1,3,4,11). In this study, no signif-
icant differences were found between the diabetic patients
and the control group (Table 2), but a correlation between
baseline ﬂow and diabetes duration was found (Fig. 3). It
is very interesting to observe that this correlation was the
opposite for the lowest and middle velocity regions, as
resolved with the quantitative LDF method. The intriguing
interpretation of this would be to relate the perfusion of
the low-velocity region (v 1 mm/s) to nutritive capillary
ﬂow, and the perfusion in the middle velocity region (1 
v  10 mm/s) to ﬂow in arterioles, venules, and arterio-
venous shunts. This interpretation is supported by the
ﬁndings that the arteriovenous shunt ﬂow is increased in
diabetic patients at baseline, resulting in a reduced nutri-
tive capillary ﬂow (8–12), although the maximal capacity
of these shunting vessels is reduced.
In conclusion, by using a novel quantitative LDF
method we have been able to compare the velocity
distribution between diabetic patients and control sub-
jects during baseline and after a local heat provocation.
Our main ﬁndings are that 1) the heat provocation
increases the blood ﬂow for velocities over 1 mm/s,
whereas blood ﬂow at lower velocities is unchanged, 2)
the reduced perfusion increase after local heating that is
observed in diabetic patients compared with control
subjects is found for velocities 10 mm/s, and 3)a
reduced low-velocity ﬂow (1 mm/s) and increased
mid-velocity ﬂow (1–10 mm/s) are related to diabetes
duration at baseline conditions. The physiologic inter-
pretations of these results are that 1) the thermoregu-
lation is a process involving primarily large, high-
velocity vessels and the increased ﬂow is shunted from
the artery to the vein side, 2) the maximal arteriovenous
shunting capacity is reduced in diabetic patients; and 3)
a long diabetes duration is associated with a reduced
nutritive capillary ﬂow due to an increased arterio-
venous shunt ﬂow at baseline conditions. All of this has
previously been known or suspected, but not proven by
direct measurements on the microcirculation.
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